SOPHiA Genetics SA
NASDAQ:SOPH 4:00:00 PM EDT
| Market Cap (Intraday) | 313.45M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.91 |
| 50-Day MA | $4.87 |
| 200-Day MA | $3.97 |
SOPHiA Genetics SA Stock, NASDAQ:SOPH
La Piece 12, Rolle, Vaud 1025
Switzerland
Phone: +41.21.694.10.60
Number of Employees: 449
Description
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.